Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

被引：404

作者：

Jenkins, Russell W. ^{[1
,2
]}

Aref, Amir R. ^{[1
,3
]}

Lizotte, Patrick H. ^{[1
,3
]}

Ivanova, Elena ^{[1
,3
]}

Stinson, Susanna ^{[4
]}

Zhou, Chensheng W. ^{[1
,5
]}

Bowden, Michaela ^{[1
,5
]}

Deng, Jiehui ^{[1
]}

Liu, Hongye ^{[1
,3
,6
]}

Miao, Diana ^{[1
,7
,8
]}

He, Meng Xiao ^{[1
,7
,8
,9
]}

Walker, William ^{[1
,3
]}

Zhang, Gao ^{[10
,11
]}

Tian, Tian ^{[12
]}

Cheng, Chaoran ^{[12
]}

Wei, Zhi ^{[12
]}

Palakurthi, Sangeetha ^{[1
,3
]}

Bittinger, Mark ^{[1
,3
]}

Vitzthum, Hans ^{[2
]}

Kim, Jong Wook ^{[1
,7
,8
]}

Merlino, Ashley ^{[1
]}

Quinn, Max ^{[1
]}

Venkataramani, Chandrasekar ^{[4
]}

Kaplan, Joshua A. ^{[4
]}

Portell, Andrew ^{[1
,3
]}

Gokhale, Prafulla C. ^{[1
,3
]}

Phillips, Bart ^{[4
]}

Smart, Alicia ^{[1
,7
,8
]}

Rotem, Asaf ^{[1
]}

Jones, Robert E. ^{[1
,3
]}

Keogh, Lauren ^{[1
,3
]}

Anguiano, Maria ^{[13
]}

Stapleton, Lance ^{[4
]}

Jia, Zhiheng ^{[4
]}

Barzily-Rokni, Michal ^{[2
]}

Canadas, Israel ^{[1
]}

Thai, Tran C. ^{[1
]}

Hammond, Marc R. ^{[2
]}

Vlahos, Raven ^{[1
,5
]}

Wang, Eric S. ^{[14
]}

Zhang, Hua ^{[1
]}

Li, Shuai ^{[1
]}

Hanna, Glenn J. ^{[1
]}

Huang, Wei ^{[1
,3
]}

Hoang, Mai P. ^{[15
]}

Piris, Adriano ^{[16
,17
]}

Eliane, Jean-Pierre ^{[15
]}

Stemmer-Rachamimov, Anat O. ^{[15
]}

Cameron, Lisa ^{[18
]}

Su, Mei-Ju ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Div Med Oncol, Boston, MA USA

[3] Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, Boston, MA 02115 USA

[4] Gilead Sci, Foster City, CA USA

[5] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA

[6] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA USA

[7] Broad Inst Harvard, Cambridge, MA USA

[8] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA

[9] Harvard Grad Program Biophys, Boston, MA USA

[10] Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA

[11] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA

[12] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA

[13] Univ Navarra, Ctr Appl Med Res, Pamplona, Spain

[14] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA

[15] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA

[16] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA

[17] Harvard Med Sch, Boston, MA USA

[18] Dana Farber Canc Inst, Confocal & Light Microscopy Core Facil, Boston, MA 02115 USA

[19] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA USA

[20] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA USA

[21] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg Oncol, Boston, MA USA

[22] MIT, Dept Mech Engn, Cambridge, MA 02139 USA

[23] Harvard Med Sch, Brigham & Womens Hosp, Div Thorac Surg, Boston, MA USA

[24] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA

来源：

CANCER DISCOVERY | 2018年 / 8卷 / 02期

关键词：

IMMUNE-CHECKPOINT BLOCKADE; REGULATORY T; KINASE TBK1; CANCER; RESISTANCE; CELLS; CTLA-4; MELANOMA; IMMUNOTHERAPY; PEMBROLIZUMAB;

D O I：

10.1158/2159-8290.CD-17-0833

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ex vivo systems that incorporate features of the tumor microenvironment and model the dynamic response to immune checkpoint blockade (ICB) may facilitate efforts in precision immuno-oncology and the development of effective combination therapies. Here, we demonstrate the ability to interrogate ex vivo response to ICB using murine-and patient-derived organotypic tumor spheroids (MDOTS/PDOTS). MDOTS/PDOTS isolated from mouse and human tumors retain autologous lymphoid and myeloid cell populations and respond to ICB in short-term three-dimensional microfluidic culture. Response and resistance to ICB was recapitulated using MDOTS derived from established immunocompetent mouse tumor models. MDOTS profiling demonstrated that TBK1/IKKe inhibition enhanced response to PD-1 blockade, which effectively predicted tumor response in vivo. Systematic profiling of secreted cytokines in PDOTS captured key features associated with response and resistance to PD-1 blockade. Thus, MDOTS/PDOTS profiling represents a novel platform to evaluate ICB using established murine models as well as clinically relevant patient specimens. SIGNIFICANCE: Resistance to PD-1 blockade remains a challenge for many patients, and biomarkers to guide treatment are lacking. Here, we demonstrate feasibility of ex vivo profiling of PD-1 blockade to interrogate the tumor immune microenvironment, develop therapeutic combinations, and facilitate precision immuno-oncology efforts. (C) 2017 AACR.

引用

页码：196 / 215

页数：20

共 50 条

[31] PD-1 blockade works alone
不详
NATURE BIOTECHNOLOGY, 2022, 40 (07) : 986 - 986
[32] Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy
Fischhaber, Natalie
Schmiedeberg, Moritz
Kuebel, Sabrina
Harrer, Ellen G. G.
Harrer, Thomas
Nganou-Makamdop, Krystelle
VACCINES, 2023, 11 (02)
[33] PD-1 BLOCKADE IN CANCER IMMUNOTHERAPY
Srivastava, N.
Avigan, D.
Rosenblatt, J.
DRUGS OF THE FUTURE, 2014, 39 (02) : 129 - 132
[34] NEOADJUVANT PD-1 BLOCKADE IN NSCLC
Killock, David
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (07) : 404 - 404
[35] Neoadjuvant PD-1 blockade in NSCLC
David Killock
Nature Reviews Clinical Oncology, 2018, 15 : 404 - 404
[36] PD-1 blockade works alone
Nature Biotechnology, 2022, 40 : 986 - 986
[37] PD-1 Blockade for Solid Tumors
不详
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 568 - 568
[38] Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa
Chen, Yichen
Li, Qiusheng
Li, Xinye
Ma, Da
Fang, Juan
Luo, Liqun
Liu, Xiangqi
Wang, Xi
Lui, Vivian Wai Yan
Xia, Juan
Cheng, Bin
Wang, Zhi
ONCOIMMUNOLOGY, 2018, 7 (02):
[39] Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma
Najjar, Yana G.
Menk, Ashley, V
Sander, Cindy
Rao, Uma
Karunamurthy, Arivarasan
Bhatia, Roma
Zhai, Shuyan
Kirkwood, John M.
Delgoffe, Greg M.
JCI INSIGHT, 2019, 4 (05)
[40] Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients
Chen, Yuan
Xue, Shao-An
Behboudi, Shahriar
Mohammad, Goran H.
Pereira, Stephen P.
Morris, Emma C.
CLINICAL CANCER RESEARCH, 2017, 23 (20) : 6178 - 6189

← 1 2 3 4 5 →